This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sheets, M. P. Articles by Trevillyan, J. M. Search for Related Content PubMed Articles by Sheets, M. P. Articles by Trevillyan, J. M. Social Bookmarking                         What's this?

A High-Capacity Scintillation Proximity Assay for the Discovery and Evaluation of ZAP-70 Tandem SH2 Domain Antagonists

Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064

Usha P. Warrior

Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064

Hosup Yoon

Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064

Karl W. Mollison

Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064

Stevan W. Djuric

Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064

James M. Trevillyan

Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064

A scintillation proximity assay (SPA) is described, which quantitates the ability of compounds to inhibit the binding interaction of a select phosphopeptide with the tandem SH2 domains of the ZAP-70 protein tyrosine kinase. The method is based on the ability of a truncated ZAP-70 tandem SH2 domain-derived peptide to bind an ¹²⁵I-labeled, diphosphorylated peptide corresponding to the human T-cell receptor -1 immunoglobulin receptor family tyrosine-based activation motif (ITAM). ZAP-70 tandem SH2 domain peptide was biotinylated and bound to streptavidin-coated SPA beads. ¹²⁵I-labeled -1 ITAM ([¹²⁵I]--1 ITAM) bound to immobilized ZAP-70 tandem SH2 domain peptide in a saturable, time- and peptide concentration-dependent fashion. Unlabeled diphosphorylated -1 ITAM competed binding with an ICso value equal to approximately 10-15 nM. Binding of -1 ITAM to the ZAP-70 tandem SH2 domain was dependent on the cooperative interaction of the dual phosphotyrosine residues. Unlabeled monotyrosyl-phosphorylated peptides failed to compete with [¹²⁵I]--1 ITAM binding to ZAP-70 SH2 domain. Also, labeled monotyrosyl-phosphorylated peptides failed to associate with the ZAP-70 SH2 domain in direct binding studies. Association and dissociation binding kinetics were determined to be extremely rapid at room temperature, reaching equilibrium within 5 min. The K_d for [¹²⁵I]--1 ITAM binding to ZAP-70 tandem SH2 domain peptide was determined by Scatchard analysis to be 1.5-2 nM. The SPA assay was adapted for automated, high-capacity screening, which allowed evaluation of 23,040 small molecular weight compounds per day. The assay is useful for both drug discovery and as a research tool for the study of binding interactions between signal-transducing molecules critical for T-cell activation.

Journal of Biomolecular Screening, Vol. 3, No. 2, 139-144 (1998)
DOI: 10.1177/108705719800300208


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Y. Hou, D. E. Mcguinness, A. J. Prongay, B. Feld, P. Ingravallo, R. A. Ogert, C. A. Lunn, and J. A. Howe Screening for Antiviral Inhibitors of the HIV Integrase--LEDGF/p75 Interaction Using the AlphaScreenTM Luminescent Proximity Assay J Biomol Screen, June 1, 2008; 13(5): 406 - 414. [Abstract] [PDF]

				S. N. Anderson, D. L. Towne, D. J. Burns, and U. Warrior A High-Throughput Soft Agar Assay for Identification of Anticancer Compound J Biomol Screen, October 1, 2007; 12(7): 938 - 945. [Abstract] [PDF]

				U. Warrior, E. M. Mckeegan, S. M. Rottinghaus, L. Garcia, L. Traphagen, G. Grayson, V. Komater, T. McNally, R. Helfrich, R. R. Harris, et al. Identification and Characterization of Novel Antagonists of the CCR3 Receptor J Biomol Screen, June 1, 2003; 8(3): 324 - 331. [Abstract] [PDF]

				U. Warrior, Y. Fan, C. A. David, J. A. Wilkins, E. M. McKeegan, J. L. Kofron, and D. J. Burns Application of QuantiGeneTM Nucleic Acid Quantification Technology for High Throughput Screening J Biomol Screen, October 1, 2000; 5(5): 343 - 351. [Abstract] [PDF]